Patient Information

Study finds clues to fibrosis progression in chronic HCV infection


 

Fibrosis progression in hepatitis C virus (HCV)–infected individuals is not linear, is associated with alanine aminotransferase–related flares, and varies according to stage, with those who are least fibrotic tending to have the highest progression, according to a recent study. Learn more about what investigators discovered and how these results can help you identify patients who are most likely to progress to cirrhosis at Family Practice News: http://www.familypracticenews.com/specialty-focus/infectious-diseases/single-article-page/study-finds-clues-to-fibrosis-progression-in-chronic-hcv-infection/02ab40880ce75d60a0c7c645a5d32db6.html.

Recommended Reading

Analysis yields ‘strong evidence’ for benefit of physical activity in NAFLD
MDedge Family Medicine
Investigational HCV drug combo yields high SVR12 rates in compensated cirrhosis
MDedge Family Medicine
Hepatitis Outlook: August 2016
MDedge Family Medicine
FDA gives orphan drug designation to BIV201 for ascites treatment
MDedge Family Medicine
Nearly half of patients readmitted after liver transplant
MDedge Family Medicine
Simple interventions markedly improve hepatitis care
MDedge Family Medicine
Targeted HCV patients improve on sofosbuvir/daclatasvir combination
MDedge Family Medicine
Direct-acting antivirals: One of several keys to HCV eradication by 2030
MDedge Family Medicine
Nonalcoholic fatty liver disease estimated to cost $103 billion annually
MDedge Family Medicine
Vitamin D deficiency linked to hepatitis B infection
MDedge Family Medicine